<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05120791</url>
  </required_header>
  <id_info>
    <org_study_id>MIA_E</org_study_id>
    <nct_id>NCT05120791</nct_id>
  </id_info>
  <brief_title>Age Related Effects Consuming Phaeodactylum Tricornutum</brief_title>
  <acronym>MIA_E</acronym>
  <official_title>Health-promoting Effects of the Microalga Phaeodactylum Tricornutum - Bioavailability and Excretion of Nutrients in Relation to Age and Their Effects on Fatty Acid Status and Inflammatory Markers&quot;.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Hohenheim</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Hohenheim</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Investigation of the microalgae Phaeodactylum as food with regard to the uptake of omega-3&#xD;
      fatty acids and effects on various blood parameters in relation to age.&#xD;
&#xD;
      Bioavailability and excretion of nutrients and their effects on fatty acid status and&#xD;
      inflammatory markers.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Due to a multifaceted redesign of all areas of life, older people face many nutritional&#xD;
      challenges, such as cognitive change, sarcopenia and micronutrient deficiency. In addition to&#xD;
      age-associated diseases, cognitive decline is usually a precursor to neurodegenerative&#xD;
      processes, such as Alzheimer's disease. The full molecular mechanisms are still unknown, but&#xD;
      classic aging mechanisms, such as oxidative stress and subclinical inflammation, play a role.&#xD;
      Due to the changed life situation, there is a reduced need for energy, while the need for&#xD;
      nutrients remains, which greatly increases the risk of malnutrition in old age. This results&#xD;
      in an increasing prevalence of sarcopenia. The decrease in muscle mass and strength leads to&#xD;
      functional limitations in the elderly and also promotes oxidative stress. This increases the&#xD;
      need for antioxidant nutrients such as carotenoids and vitamins. Studies show that&#xD;
      age-related chronic subclinical inflammation, such as occurs in the context of an omega-6&#xD;
      fatty acid (-FS) emphasized diet, plays a central role in the pathogenesis of age-associated&#xD;
      diseases&#xD;
&#xD;
      Due to this, the microalgae PT could be a goud supplier of nutrients like omega-3 FS,&#xD;
      especially eicosapentaenoic acid (EPA), which is otherwise found mainly in fatty fish, and&#xD;
      Fucoxanthin, an antioxidant. The investigator study the change of omega-3, -6 and -9 FS in&#xD;
      blood plasma, in erythrocytes, as well as the change of fucoxanthin and beta-carotene. The&#xD;
      investigator measure blood parameters for safety and control the influence on the intestinal&#xD;
      barrier.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Anticipated">November 2021</start_date>
  <completion_date type="Anticipated">December 2021</completion_date>
  <primary_completion_date type="Anticipated">December 2021</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>4 arm parallel groups</intervention_model_description>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change in omega-6/omega-3 ratio (plasma level basis)</measure>
    <time_frame>14 days</time_frame>
    <description>fatty acid chromatographic measurement</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Omega-3 fatty acid index</measure>
    <time_frame>14 days</time_frame>
    <description>fatty acid chromatographic measurement in red blood cells</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Uptake of fucoxanthin and beta-carotene</measure>
    <time_frame>14 days</time_frame>
    <description>chromatographic measurement in plasma</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Inflammation (CRP)</measure>
    <time_frame>14 days</time_frame>
    <description>measurement in blood serum</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Markers for oxidative stress</measure>
    <time_frame>14 days</time_frame>
    <description>lipid hydroperoxides)</description>
  </other_outcome>
  <other_outcome>
    <measure>Albumin</measure>
    <time_frame>14 days</time_frame>
    <description>Measurement in serum</description>
  </other_outcome>
  <other_outcome>
    <measure>weight</measure>
    <time_frame>14 days</time_frame>
    <description>in kilograms</description>
  </other_outcome>
  <other_outcome>
    <measure>FFQ- Food frequence questionnaire</measure>
    <time_frame>4 weeks</time_frame>
    <description>Food questionnaire about the general eating of the last 4 weeks</description>
  </other_outcome>
  <number_of_arms>4</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Aging</condition>
  <condition>Well Aging</condition>
  <arm_group>
    <arm_group_label>Placebo</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>14 days wahs-out: no fish eating 14 days: no fish eating, the participants eat vegetable bouillon (1,3g)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Microalgae phaeodactylum</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>14 days wahs-out: no fish eating 14 days: no fish eating, the participants eat vegetable bouillon (1.3g), 2.3g Microalgae Phaeodactylum</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Beta-Glucan</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>14 days wahs-out: no fish eating 14 days: no fish eating, the participants eat vegetable bouillon (1.3g), Beta-Glucan (1.8g)</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Combi Microalgae phaeodacytlum and Beta-Glucan</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>14 days wahs-out: no fish eating 14 days: no fish eating, the participants eat vegetable bouillon (1.3g), 2.3g Microalgae, Beta-Glucan (1.8g)</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>Placebo vegetable bouillon</intervention_name>
    <description>14 days wahs-out: no fish eating 14 days: no fish eating, the participants eat vegetable bouillon (1,3g)</description>
    <arm_group_label>Placebo</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>microalgae phaeodactylum</intervention_name>
    <description>14 days wahs-out: no fish eating 14 days: no fish eating, the participants eat vegetable bouillon (1.3g), 2.3g Microalgae Phaeodactylum</description>
    <arm_group_label>Microalgae phaeodactylum</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>From the Microalgae phaeodactylum the extracted beta-Glucan (especially chrysolaminarin)</intervention_name>
    <description>14 days wahs-out: no fish eating 14 days: no fish eating, the participants eat vegetable bouillon (1.3g), Beta-Glucan (1.8g)</description>
    <arm_group_label>Beta-Glucan</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>A combination of the vegetable bouillon, the microalgae and the beta-Glucan</intervention_name>
    <description>14 days wahs-out: no fish eating 14 days: no fish eating, the participants eat vegetable bouillon (1.3g), 2.3g Microalgae, Beta-Glucan (1.8g)</description>
    <arm_group_label>Combi Microalgae phaeodacytlum and Beta-Glucan</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
        Age ≥60 ≤90 years, weight ≥50 kg, generally healthy&#xD;
&#xD;
          -  Signed informed consent form&#xD;
&#xD;
          -  Willingness to follow the prescribed diet for the duration of the study&#xD;
&#xD;
          -  No participation in any other clinical trial (current or within the last 30 days)&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Taking intestinal therapeutics, antibiotics, immunosuppressants or similar. (if&#xD;
             necessary, decision on a case-by-case basis)&#xD;
&#xD;
          -  Pregnancy/breastfeeding&#xD;
&#xD;
          -  Relevant violations of the dietary protocol&#xD;
&#xD;
          -  Occurrence of relevant diseases (if necessary, individual case decision)&#xD;
&#xD;
          -  Withdrawal of consent&#xD;
&#xD;
          -  Placement in a clinic or similar facility due to official or court order&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>65 Years</minimum_age>
    <maximum_age>90 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Stephan C Bischoff, Prof. Dr</last_name>
    <phone>0711 459 24101</phone>
    <email>bischoff.stephan@uni-hohenheim.de</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Lena Stiefvatter, M.SC</last_name>
    <phone>071145924881</phone>
    <email>lena.stiefvatter@uni-hohenheim.de</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Stephan C. Bischoff, Prof. Dr</name>
      <address>
        <city>Stuttgart</city>
        <state>Baden-Württemberg</state>
        <country>Germany</country>
      </address>
    </facility>
    <status>Recruiting</status>
  </location>
  <location_countries>
    <country>Germany</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>October 26, 2021</study_first_submitted>
  <study_first_submitted_qc>November 3, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 15, 2021</study_first_posted>
  <last_update_submitted>November 3, 2021</last_update_submitted>
  <last_update_submitted_qc>November 3, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University of Hohenheim</investigator_affiliation>
    <investigator_full_name>Stephan C. Bischoff, MD, Professor</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>Microalgae</keyword>
  <keyword>omega-3 fatty acids</keyword>
  <keyword>Micronutrients</keyword>
  <keyword>carotinoids</keyword>
  <keyword>Inflammation</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

